• 1. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 5. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 2-Pyrrolidinecarboxamide, N-methyl-, (2S) and Its Significance in Modern Chemical Biology

2-Pyrrolidinecarboxamide, N-methyl-, (2S), identified by its CAS number 52060-82-9, is a compound of considerable interest in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique pyrrolidine core structure and (2S) configuration, has garnered attention due to its potential applications in drug discovery and molecular pharmacology. The pyrrolidine scaffold is a common motif in biologically active molecules, often contributing to their binding affinity and metabolic stability. The N-methyl substitution further enhances its structural diversity, making it a valuable candidate for synthetic chemistry and medicinal chemistry investigations.

The significance of 2-Pyrrolidinecarboxamide, N-methyl-, (2S) lies in its versatility as a building block for more complex pharmacophores. Researchers have leveraged this compound to develop novel therapeutic agents targeting various biological pathways. Its stereochemical purity, particularly the (2S) configuration, is critical for ensuring the efficacy and safety of derived drug candidates. Recent advancements in chiral synthesis have enabled the efficient production of enantiomerically pure forms of this compound, facilitating more precise pharmacological studies.

In the context of contemporary chemical biology, 2-Pyrrolidinecarboxamide, N-methyl-, (2S) has been explored for its interactions with enzymes and receptors. Its pyrrolidine ring can mimic natural substrates or inhibitors, providing insights into enzyme mechanisms and potential drug targets. For instance, studies have demonstrated its utility in modulating enzymes involved in metabolic pathways, such as those relevant to diabetes and obesity. The N-methyl group also plays a role in determining the compound's solubility and bioavailability, which are crucial factors in drug development.

One of the most compelling aspects of 2-Pyrrolidinecarboxamide, N-methyl-, (2S) is its application in the design of peptidomimetics. Peptidomimetics are synthetic analogs of natural peptides that retain biological activity but exhibit improved pharmacokinetic properties. The pyrrolidine core can replace amino acid residues in peptide sequences, enhancing stability while preserving receptor binding affinity. This approach has been particularly successful in developing treatments for neurological disorders, where peptide-based therapies face challenges related to degradation and immunogenicity.

Recent research has also highlighted the role of 2-Pyrrolidinecarboxamide, N-methyl-, (2S) in addressing inflammatory diseases. Inflammatory processes often involve complex signaling pathways regulated by enzymes such as kinases and phosphatases. By serving as a scaffold for inhibitor design, this compound has been used to develop molecules that selectively modulate these pathways. For example, derivatives of 2-Pyrrolidinecarboxamide, N-methyl-, (2S) have shown promise in preclinical studies for their ability to inhibit inflammatory cytokine production without causing significant side effects.

The synthesis of 2-Pyrrolidinecarboxamide, N-methyl-, (2S) has been refined through modern catalytic methods, including asymmetric hydrogenation and transition metal-catalyzed reactions. These techniques allow for high yields and enantioselectivity, which are essential for producing pharmaceutical-grade materials. The growing interest in green chemistry has further driven innovation in synthetic protocols, with an emphasis on sustainable practices that minimize waste and energy consumption.

In conclusion, 2-Pyrrolidinecarboxamide, N-methyl-, (2S) represents a significant advancement in chemical biology and drug discovery. Its unique structural features make it a versatile tool for developing novel therapeutic agents targeting a wide range of diseases. As research continues to uncover new applications for this compound, its importance in pharmaceutical science is likely to grow further. The combination of traditional organic synthesis with cutting-edge biotechnological approaches ensures that compounds like 52060-82-9 will remain at the forefront of medicinal chemistry innovation.

• 55478-46-1(N-octyl-5-oxo-pyrrolidine-2-carboxamide)
• 174089-62-4(2-Pyrrolidinecarboxamide,N-(1-methylethyl)-, (2S)-)
• 16395-57-6((S)-5-Oxopyrrolidine-2-carboxamide)
• 56104-32-6(2-PYRROLIDINECARBOXAMIDE, N-DODECYL-5-OXO-, (S)-)
• 49864-48-4(Prolylglycinamide)
• 137693-34-6(N-methylpyrrolidine-2-carboxamide)
• 176692-69-6(N-(4-Amino-4-oxobutyl)-L-prolinamide)
• 1225063-04-6(H-D-Pro-NHEt·HCl)
• 55647-42-2(2-PYRROLIDINECARBOXAMIDE, N-HEXYL-, (S)-)
• 87379-99-5(GLYCINAMIDE, 5-OXO-L-PROLYL-)